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ABSTRACT 
Six new nickel (II) complexes with a series of tetrazole derivatives functionalized by different 
substituents {5-(2-(1-Benzyltetrazol-5-yl) phenyl)-2-ethyl-4-methylthiazole (L1), 1-Benzyl-5-(2-(1-
methylpyrrol-2-yl)phenyl) tetrazole (L2), 5-(2-(1-Pivalyltetrazol-5-yl)phenyl)-2-ethyl-4-
methylthiazole (L3), 5-(2-(1-Methylpyrrol-2-yl) phenyl)-1-pivalyltetrazole (L4), 2-Ethyl-4-methyl-
5-(2-(1 methyltetrazol-5-yl) phenyl) thiazole (L5) and 1-Methyl-5-(2-(1-methylpyrrol-2-yl)phenyl) 
tetrazole (L6)} have been synthesized and characterized by analytical and spectral methods. The 
data clearly indicated that the nickel (II) complexes are coordinated to the monodentate tetrazole 
derivatives via nitrogen (N3) atom of the tetrazole ring. The octahedral geometry is observed for all 
the complexes. The thermogravimetric analysis revealed the presence of coordinated and hydrated 
water molecules in the coordination sphere. The DFT calculations performed on both the ligands 
and the complexes allowed to optimize the structures, the stability and to explain the 
electrochemical behavior and the biological activities of the nickel (II) complexes.
The study of the substituents effects on the redox properties of the ligands and their nickel (II) 
complexes were discussed via cyclic voltammograms. Electron donating substituents shift the 
reduction potentials toward negative values, while anodic shift of the oxidation potentials is 
manifested by the substituents having an electron withdrawing effect.    
The in vitro antimicrobial activities of the ligands and their corresponding nickel (II) complexes 
have been evaluated against four bacterial and two fungal strains.  
*Corresponding author. Laboratoire d’Hydrométallurgie et Chimie Inorganique Moléculaire,
Faculty of Chemistry, Houari Boumediene Technologies Sciences University (U.S.T.H.B), 
BP32 El Alia Algiers, Algeria.
E-mail address: yacinecm34@gmail.com
2L1-L6 ligands and their nickel (II) complexes showed a better activity against Gram-positive 
bacteria. The reactivity of the complexes against Streptococcus group D varied from very sensitive 
to extremely sensitive activity. No activity has been recorded for the six ligands against the tested 
fungal strains but their complexes showed extremely sensitive antifungal activity against these 
strains. The electron donating effect of the substituents was found to weaken the antimicrobial 
activity of the complexes. 
The antioxidant activity of the compounds has been evaluated using the DPPH method. The results 
indicated that the ligands and their nickel (II) complexes exhibited a better activity against the 
radical DPPH in comparison to the used reference. Electron withdrawing effect of the substituents 
on the ligands enhanced the antioxidant activity of the ligands and their complexes. 
Keywords:  Nickel (II) complex, Tetrazole derivatives, DFT, TGA, cyclic voltammetry, biological 
activity.
1. INTRODUCTION
Microbial infection is one of the major threats in the world. For this reason, researches in medicinal 
chemistry have been interested in the development of many antimicrobial agents and widely used to 
treat them. But from the beginning of the development, the resistance of microorganisms to 
antimicrobial agents was recognized. In this regard, there is always a need for the identification of 
novel chemical compounds with antimicrobial activities [1-6].
Tetrazole derivatives form an important class of compounds that possess interesting 
pharmacological and biological properties [7]. Many studies dealing with the synthesis of new 
tetrazole derivatives having biological activities are published [8-14]. These compounds possess 
antimicrobial, anticancer and other biological activities. It is not a coincidence that these 
compounds are incorporated in a large number of drugs approved by food and Drug Administration 
(FDA) and World Health Organisation (WHO) [15]. Tetrazole rings are considered as an important 
descriptor in the methodology of the design of new drugs using the analogue based drug discovery 
(ABDD) method [16].
The chemistry of transition metal complexes containing nitrogen, oxygen and other donors has 
attracted a great attention [17-20]. This is due to the fact that the biological properties of the 
coordinated ligands increase upon complexation with metal ions [21, 22].  
For many years, nickel was not considered to play an important biological role. This fact has 
completely changed with the discovery of the presence of nickel in the active center of the enzyme 
urease [23]. Since then, the determination of nickel-containing or dependent enzymes was the main 
3factor of the biological expanded of nickel [24]. Furthermore, a lot of nickel complexes acting as 
antimicrobial [25-27] and anti-inflammatory [28] activity was also found in the literature.
In this context, we report the effect of the functionalized tetrazole ring on the electrochemical 
behavior and biological activities of new nickel (II) complexes. These complexes are formed at 
solid state with a series of tetrazole derivatives L1-L6previously synthesized by our group [29] and 
containing different substituents (scheme1). Analytical and spectral methods were used to 
characterize the complexes. Density functional theory (DFT) calculations were carried out to 
optimize the geometry of the nickel complexes.  The theoretical results have then been correlated 
with the experimental data in order to confirm the coordination mode of the ligands to the metal ion.  
The electrochemical properties of the ligands and their nickel (II) complexes were investigated by 
the cyclic voltammetry. These compounds were then subjected to in vitro antibacterial activity 
against two Gram-negative (Echerichia Coli, Klebsiella pneumoniae) and two Gram-positive 
(Staphylococcus aureus, Streptocoque D) bacterial strains and for in vitro antifungal activity against 
(Candida albicans and Trichophyton rubrum)fungal strains. The antioxidant activity of the entire 
compounds using the DPPH method has also studied.
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Scheme 1. Structure of the different ligands.
The electronic effects of (Benzyl, Pivaloyl and Methyl) substituents located in position 1 and ([2-(2-
ethyl-4-methylthiazol) phenyl], [2-(1-methyl pyrrol-2-yl) phenyl]) substituents located in position 5 
of the ligands (scheme 1) on the electrochemical behavior and the biological activities of the ligands 
and their nickel (II) complexes have been discussed. 
42. Experimental
2.1. Reagents
All reagents used were analytical grade, solvent (Merck) such as ethanol and Dimethyl Sulfoxide 
(DMSO) were used without farther purification; NiCl2. 6H2O (FluKa).
2.2. Synthesis of ligands 
2.2.1. synthesis of  L1and L2 ligands
5-(2-(1-Benzyltetrazol-5-yl)phenyl)-2-ethyl-4-methylthiazole(L1:Scheme1) and 1-Benzyl-5-(2-(1-
methylpyrrol-2-yl)phenyl) tetrazole (L2: Scheme1) were synthesized following the general 
procedure [29], using a mixture of 1-benzyl-5-(2-bromophenyl)tetrazole (0.5mmol), Potassium 
pivalate (PivoK) (1mmol), 0.1mmol PdCl(C3H5) (dppb) in 2ml of DMA and 2-ethyl-4-
methylthiazole (0.75mmol) for L1 ligand and 2mmol of N-methylpyrrole for L2 ligand. The 
reactions were performed at 150oC under argon atmosphere, the coupling product obtained after 
evaporation of the solvent and purification on silica gel (Pentane-Et2O/ 70:30).  
2.2.2. synthesis of  L3and L4 ligands
5-(2-(1-Pivalyltetrazol-5-yl)phenyl)-2-ethyl-4-methylthiazole(L3: Scheme1) and 5-(2-
(1Methylpyrrol-2-yl)phenyl)-1-pivalyltetrazole (L4: Scheme1) were prepared following the general 
procedure [29], using a mixture of 0.5mmol of 5-(2-bromophenyl)-1-pivalyltetrazole, 1mmol of 
PivoK, 0.1mmol of PdCl(C3H5) (dppb) in 2ml of DMA and 0.75mmol of 2-ethyl-4-methylthiazole 
for L3 ligand and 2mmol of  N-methylpyrrole for L4 ligand. The reactions were performed at 150oC 
under argon atmosphere, the coupling product obtained after evaporation of the solvent and 
purification on silica gel (Pentane-Et2O/ 70:30).  
2.2.3. synthesis of  L5and L6 ligands
2-Ethyl-4-methyl-5-(2-(1-methyltetrazol-5-yl)phenyl) thiazole (L5: Scheme1) and 1-Methyl-5-(2-
(1-methylpyrrol-2-yl)phenyl)tetrazole (L6: Scheme1) were prepared following the general 
procedure [29], using a mixture of 0.5mmol of 5-(2-bromophenyl)-1-methyltetrazole, 1mmol of 
PivoK, 0.1mmol of PdCl(C3H5) (dppb) in 2ml of DMA and 0.75mmol of 2-ethyl-4-methylthiazole 
for L5 ligand and 2mmol of  N-methylpyrrole for L6 ligand. The reactions were performed at 150oC 
under argon atmosphere, the coupling product obtained after evaporation of the solvent and 
purification on silica gel (Pentane-Et2O/ 70:30).
52.3. Synthesis of complexes 
Nickel complexes were prepared by adding drop wise an ethanolic solution (1 mmol) of Ni Cl2. 
6H2O to a solution of ligands (2 mmol) dissolved in the same solvent in 1:2metal to ligand molar 
ratio. The mixture turned immediately to green was heated under reflux over 5h. The obtained 
precipitated complexes were then filtered off, washed with distiller water and ethanol, dried at 50oC 
and finally stored in flasks.
2.3.1. [Ni L12 Cl2 (H2O)2] .2H2O: calculated: C, 51.96; H, 4.14; N, 15.15; S, 6.94; Cl, 7.67; Ni, 
6.35%; found: C, 51.5; H, 4.4; N, 15.7; S, 6.1; Cl, 7.1; Ni, 7.1%.
2.3.2. [Ni L22 Cl2 (H2O)2] .2H2O: calculated: C, 54.83; H, 4.12; N, 16.83; Cl, 6.11; Ni, 7.05%; 
found: C, 55.1; H, 4.8; N, 16.7; Cl, 5.9; Ni, 7.1%.
2.3.3. [Ni L32 Cl2 (H2O)2] .2H2O: calculated: C, 47.38; H, 4.64; N, 15.33; S, 7.03; Cl, 7.77; Ni, 
6.43%; found: C, 46.1; H, 4.6; N, 16.1; S, 6.9; Cl, 7.2; Ni, 6.8%.
2.3.4. [Ni L42 Cl2 (H2O)2] .2H2O: calculated: C, 49.78; H, 4.69; N, 17.07; Cl, 8.64; Ni, 7.90%; 
found: C, 49.1; H, 4.4; N, 17.3; Cl, 8.1; Ni, 6.9%.
2.3.5. [Ni L52 Cl2 (H2O)2] .2H2O: calculated: C, 43.54; H, 3.91; N, 18.13; S, 8.39; Cl, 9.18; Ni, 
7.60%; found: C, 44.0; H, 3.8; N, 18.1; S, 9.1; Cl, 9.3; Ni, 6.9%. 
2.3.6. [Ni L62 Cl2 (H2O)2] .2H2O: calculated: C, 45.91; H, 3.85; N, 20.6; Cl, 10.42; Ni, 8.63%; 
found: C, 46.1; H, 3.7; N, 20.1; Cl, 9.8; Ni, 8.1%.
2.4. Analytical and Physical measurements
The elemental microanalysis was carried out using a Perkin–Elmer Analyser 2400. Melting points 
were measured using a digital melting points apparatus SMP3 using capillary technique.  The molar 
conductance measurements of the complexes were carried out using JENWAY-4520 at 25oC and 
10-3M in DMSO. 
The IR spectra of the ligands and their complexes were carried out using a Perking Elmer FT-IR 
spectrometer in 4000- 400 cm-1 range on KBr pellets. The electronic absorptions were measured 
with Jasco v-630 spectrophotometer in the range 190-1000 nm in DMSO solution (10-4 M). The 
magnetic measurements were carried out using SQUID magnetometer in 200-300 K range with 
an applied field 10,000 G.
6Thermogravimetric analysis (TGA) was obtained on a SDT Q 600 TA instrument in dynamic 
nitrogen atmosphere (10oC. min-1 in 50-950oC temperature range). 
The cyclic voltammograms were conducted at room temperature with analyte concentrations of 1 
mM in DMSO and tetrabutylammonium perchlorate (TBAP) as the supporting electrolyte. All 
solution were purged at least 15 min with nitrogen. The three electrodes system consisted of a 
platinum wire as the working electrode, a platinum foil as the counter electrode and a SCE 
(Saturated Calomel Electrode) as the reference electrode.    
2.5. Computational methods
The Geometry optimization of the complexes in the ground state have been accomplished by 
Density Functional Theory (DFT) method using Beck’s three parameters hybrid method and the 
Lee- Yang- Parr (B3LYP) correlation functional [30-32].
The LANL2DZ basis set was carried out for all atoms, as implemented by Gaussian 03W package 
[33] in gas phase. To make sure that the stationary points of the studied complexes were minima the 
vibrational frequencies were computed and their vibrational spectra were analyzed using Gaussview 
software. 
The Natural Bond Orbital (NBO) program was used in order to perform the population analysis [34] 
at the same level of theory.
2.6. Biological studies
2.6.1. Antimicrobial activity
L1-L6 ligands and their nickel (II) complexes were screened in vitro for their antimicrobial activity 
using agar-well diffusion method [35, 36]. The in vitro antibacterial activity was carried out in 
nutrient broth Mueller Hinton (MH) at 37°C for 24 h, against two Gram-negative (E. Coli ATCC 
4157, Klebsiella pneumonia ATCC 4352) and two Gram-positive (Staphylococcus aureus ATCC 
6538, Streptocoque D ATCC 25923) bacterial strains. Whereas the antifungal activity was carried 
out in Sabouraud Dextrose Broth (SAB) at 28°C for 48 h, against (Candida albicans ATCC 24433 
and Trichophyton rubrum ATCC 1683)fungal strains. About 1 ml of young bacterial and fungal 
inocula containing approximately 106 CFU/ml Colony Forming Unite was spread on the surface of 
the nutrient agar and Sabouraud Dextrose Broth, with the help of a sterile cotton swab. The tested 
compounds were dissolved in DMSO solvent at concentration of 5 and 10 mg/ml [37, 38]. The 
wells (6mm in diameter) were punched carefully using a sterile Pipette Pasteur and 25µL of tested 
solutions at different concentrations were added into each labeled well. Other wells supplemented 
with DMSO and Ni Cl2. 6 H2O served as negative controls.
7The results are measuring by the diameter of the zones of inhibition that appeared around the wells.  
The sensitivity of the different compounds was classified by the diameter of the inhibition halos as: 
not sensitive for diameters less than 8 mm; sensitive for diameters 9–14 mm; very sensitive for 
diameters 15–19 mm and extremely sensitive  for diameters larger than 20 mm [39]. 
2.6.2. Antioxidant studies
The 2, 2-diphenyl-1-picryl-hydrazyl (DPPH) radical scavenging activity of the different ligands (L1-
L6) and their nickel (II) complexes was measured according to the method of Blois [40]. The DPPH 
radical is a stable free radical that absorbs (λmax) at 517 nm. A fixed concentration (50 µM) of the 
tested compounds was added to a methanolic solution containing DPPH radicals (1mM, 1mL). The 
final volume was 4 ml. the mixture was shaken vigorously and left in the dark for 30 min. the 
decrease in absorbance of DPPH was measured at 517nm using Jasco V-630 spectrophotometer. 
The same procedure was repeated for reference compound (Chlorogenic acid). 
The antioxidant capacity of our products is expressed as percentage inhibition of the DPPH radical 
(% of reduced DPPH) by the following relation [41]:
%scavenging effect = [(ADPPH - AS)]/ADPPH] x 100
ADPPH is the absorbance of DPPH in methanol.
AS  is the absorbance of the tested compounds at 517nm.
Calibration curve of ascorbic acid (Fig S1, Supplementary Items) was plotted and used to estimate 
the antioxidant power of the ligands and their nickel (II) complexes, which will be expressed in 
ascorbic acid equivalent.
83. Results and discussion
3.1. Physical properties of the metal complexes 
The physical properties of the synthesized nickel (II) complexes are summarized in Table 1. The 
molar conductivity measurements suggest that all the synthesized complexes are non-electrolytes 
[42-44] indicating that the two chloride are inside the metal coordination sphere. The complexes are 
green in color and are insoluble in water, ethanol and methanol but soluble in dimethyl Sulfoxide 
(DMSO) and N, N-dimethyl formamide (DMF).
Table 1.  Physical properties of the metal complexes.
3.2. Infrared spectra 
In order to determine the coordination site of our ligands, a comparison of the IR spectra of our 
ligands and their nickel complexes was carried out. From the IR spectra of the ligands and their 
complexes, we extracted some characteristic stretching vibration bands that could help and guide us 
to achieve this goal. Significant wave numbers are listed in Table 2.
Complexes Melting point °C Yield % Conductance
Ω-1 cm2 mol-1
μeff
(B.M)
[Ni L12 Cl2(H2O)2] .2H2O >300 55 18 3.01
[Ni L22 Cl2 (H2O)2] .2H2O >300 51 26 3.14
[Ni L32 Cl2 (H2O)2] .2H2O >300 39 37 3.30
[Ni L42 Cl2 (H2O)2] .2H2O >300 46 41 3.41
[Ni L52 Cl2 (H2O)2] .2H2O >300 54 33 2.77
[Ni L62 Cl2 (H2O)2] .2H2O >300 56 13 2.82
9Table 2.The main absorbance bands (cm-1) in FT-IR spectra and their assignments for the ligands 
and their complexes.
 (Calc)= Calculated by DFT     
The IR spectrum of each free ligand show a characteristic absorption bands near 1300 cm-1 assigned 
to (-N-N=N-) stretching vibration of the tetrazole ring [45-47], a medium intensity bands in the 
region 1447-1510 cm-1 which might be due to (C=N) tetrazole and (N=N) stretching vibration of the 
tetrazole ring [48]. The (C=O) stretching vibration band is observed at 1687 and 1683 cm-1 for L3 
and L4 ligands, respectively [49]. 
Compound υ (C=N) tetrazole υ (N=N) υ (N-N=N) υ(OH)H2OCoord υ (C=O) υ (M-O) υ (M-N)
L1 1510
(1518)
1457
(1459)
1329
(1326)
- - - -
L2 1514
(1497)
1461
(1452)
1316
(1311)
- - - -
L3 1489
(1481)
1452
(1457)
1326
(1330)
- 1687
(1691)
- -
L4 1494
(1491)
1456
(1465)
1309
(1311)
- 1683
(1681)
- -
L5 1483
(1476)
1447
(1466)
1319
(1318)
- - - -
L6 1488
(1482)
1452
(1458)
1284
(1278)
- - - -
Ni-L1 1500
(1492)
1431
(1418)
1254
(1252)
3479
(3526)
- 467
(424)
525
(521)
Ni-L2 1475
(1474)
1416
(1416)
1265
(1267)
3468
(3515)
- 464
(423)
524
(545)
Ni-L3 1473
(1463)
1418
(1401)
1252
(1258)
3477
(3542)
1637
(1643)
471
(433)
522
(518)
Ni-L4 1480
(1470)
1410
(1397)
1263
(1259)
3448
(3545)
1631
(1634)
465
(431)
523
(531)
Ni-L5 1483
(1481)
1418
(1409)
1258
(1264)
3467
(3539)
- 464
(449)
536
(538)
Ni-L6 1475
(1470)
1408
(1410)
1271
(1285)
3467
(3531)
- 464
(450)
525
(543)
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Fig. 1.Experimental Infrared vibrational spectra of L4 ligand (red line) and Ni–L4 complex (blue 
line) and Simulated IR spectrum of Ni–L4 complex (black line).
The results presented in Table 2 showed that (C=N) tetrazole, (N=N) and (N-N=N) stretching 
vibrations of the varied ligands are different. This leads us to assume that the difference between 
these stretching vibrations is due to the electronic effect of the substituents located in position 1 
and5 on the ligands (scheme 1)  [50, 51].  It is expected that the position and/ or the intensity of 
these absorption bands will be changed upon complexation.  
The IR spectra of the complexes reveal that the stretching vibration band of (N=N) is affected by 
complexation and shifted toward lower frequencies by 26-46 cm-1, the shift to lower frequencies of 
(N-N=N) band is observed for all complexes by 58-75 cm-1 and a slight shift appeared toward lower 
frequencies for (C=N) tetrazole stretching vibration band.  The big shift toward lower frequencies of 
(N=N) and (N-N=N) stretching vibrations bands and the slight shift of (C=N) band of the 
coordinated ligands leads us to deduce the involvement of (N=N) group in the complexation.  It is 
11
also noted that (C=O) stretching vibration for both L3 and L4 ligands remained unaffected by the 
complexation which indicates that this group was not involved in the coordination.
The bonding between ligand and metal ion is also confirmed by the presence of new bands in the IR 
spectra of the complexes around 450 and 520 cm-1 assigned to M-O and M-N, respectively [52]. 
The stretching vibration of coordinated water molecules appeared in the range 3448-3479cm-1 [53]. 
The theoretical IR spectra were obtained with the help of DFT calculations using B3LYP method 
with the LANL2DZ basis set. The simulated and experimental IR spectra of ligands and their nickel 
(II) complexes are presented in Fig. 1. The nickel (II) complexes IR spectra are in good agreement 
with the experimental spectra. These spectra were used to confirm the experimental assignments.
3.3. Electronic spectra 
The electronic spectra of the different ligands (L1-L6) and their nickel (II) complexes are measured 
in DMSO solution and presented in table 3 and 4 respectively, and the electronic absorption spectra 
of L5 ligand and the corresponding Ni (II) complex are given in fig. 2.
It is noted from Table3 that all the ligands exhibit absorption bands and shoulders between 240nm 
(41667cm-1) and 325nm (30769 cm-1) and they are due to the intraligand transitions π→π* and 
n→π*respectively [54].
Table 3. The main absorbance bands (cm-1) of the ligands in UV-visible and their assignments.
Ligand λ nm (cm-1) ε (mole-1. L. cm-1) Electronic transitions
L1 273 (36630)
315 (31055)
30300
14500
π→π*
n→π*
L2 246 (40650)
317 (31545)
14270
22900
π→π*
n→π*
L3 250 (40000)
302 (33557)
14890
18300
π→π*
π→π*
L4 244 (40983)
282(35971)
11330
28200
π→π*
n→π*
L5 281 (35587)
316 (31646)
34600
22100
π→π*
n→π*
L6 275 (36101)
324 (30864)
68800
16700
π→π*
n→π*
12
 A band at 275 nm and a shoulder between 300-330 nm are showed on L1 spectrum. L2 spectrum 
presents also a band at 246 nm and a shoulder between 300-330 nm.   
L3 spectrum exhibits a band at 250 nm and a shoulder between 295-310 nm. L4 spectrum presents a 
shoulder between 240-250 nm and another one between 275-290 nm.   
L5 spectrum shows two shoulders between 275-290nm and between 310-320nm. L6 spectrum 
exhibits also two shoulders the first one between 265-280nm and the second one between 315-
330nm. 
The difference in the observed electronic absorptions could be related to the different electronic 
effect of the substituents (Benzyl, Pivaloyl and Methyl) located in position 1 and ([2-(2-ethyl-4-
methylthiazol) phenyl], [2-(1-methyl pyrrol-2-yl) phenyl]) located in position 5 of the ligands 
(scheme 1) [55, 56].  
It is also noted from Table 3 that L1, L3 and L5 ligands show electronic absorptions at higher 
wavelengths in comparison to L2, L4 and L6 ligands. The higher electron donating effect of ([2-(2-
ethyl-4-methylthiazol) phenyl] group carried by L1, L3 and L5 ligands in position 5 could explain 
this result. L3 and L4 ligands show electronic absorptions at the smallest wavelengths; this is 
attributed to the higher electron withdrawing effect of the Pivaloyl substituent located in position 1 
of the ligands [57].   
Fig. 2.Electronic spectra of (a) L5 and (b+c) Ni-L5
The electronic data of the complexes are summarized in Table 4.Five absorption bands are observed 
for all complexes. Two are located in UV region in the range260-280nm and 315-335 nm due to the 
π→π* and n→π* intraligand transitions [30, 37] and are displaced with respect in the ligands. This 
indicates that the ligands are present around the central metal. 
Three bands present in the range  380-395nm, 660-685nm and 980-1000 nm could be attributed to 
3A2g(F)→ 3T2g(F), 3A2g(F)→ 3T1g(F) and 3A2g(F)→ 3T2g(P) d-d transitions, respectively. These 
absorption ranges correspond to the composition of well-selected octahedral configuration around 
Ni (II) [58-60]. The observed magnetic moment values (table 1) of nickel complexes indicate the 
13
paramagnetic nature of Ni (II), which confirms the octahedral structure of these nickel complexes 
[30, 37, 38].
Table 4. The main absorbance bands (cm-1) of Ni (II) complexes in UV-visible and their 
assignments.
Compounds Wavenumber
ῡ (cm-1)
Wavelength
λ (nm)
Molar coefficient absorption
(mole-1. L. cm-1)
Electronic transition
Ni-L1
37735
31055
25316
15060
10080
265
322
395
664
992
1009
583
302
110
78
π→π*
n→π*
3A2g(F) →3T2g(F)
3A2g(F) →3T1g(F)
3A2g(F) →3T2g(P)
Ni-L2
36630
30303
25706
14925
10152
273
330
389
670
985
833
490
343
154
112
π→π*
n→π*
3A2g(F) →3T2g(F)
3A2g(F) →3T1g(F)
3A2g(F) →3T2g(P)
Ni-L3
36496
30864
25575
15015
10141
274
324
391
666
986
718
453
287
145
111
π→π*
n→π*
3A2g(F) →3T2g(F)
3A2g(F) →3T1g(F)
3A2g(F) →3T2g(P)
Ni-L4
40816
31446
25641
14771
10141
275
318
390
677
986
938
736
402
160
101
π→π*
n→π*
3A2g(F) →3T2g(F)
3A2g(F) →3T1g(F)
3A2g(F) →3T2g(P)
Ni-L5
37735
30864
25316
15015
10070
265
324
395
666
993
1273
547
304
104
70
π→π*
n→π*
3A2g(F) →3T2g(F)
3A2g(F) →3T1g(F)
3A2g(F) →3T2g(P)
Ni-L6
37735
30769
25316
14992
10091
265
325
395
667
991
1000
483
321
139
97
π→π*
n→π*
3A2g(F) →3T2g(F)
3A2g(F) →3T1g(F)
3A2g(F) →3T2g(P)
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3.4. Thermogravimetric analysis
The thermogravimetric analysis (TGA) for the different complexes was carried out using SDT 
Q600 TA Instrument. Heated from 50-950oC in a covered Aluminum sample holders. A heating rate 
of 10oC per min was employed and 100ml per min dynamic nitrogen atmosphere. The 
thermogravimetric data of the complexes are summarized in Table 5.
The TGA curves of the complexes are very similar and that of Ni-L1 (Fig. 3) and Ni-L4 (Fig S2, 
Supplementary Items) were discussed as examples. 
Table5.Thermogravimetric results of the complexes.
Based on the literature, mechanisms of the thermal decomposition for Ni-L1 and Ni-L4 complexes 
are proposed and presented in Fig. 4 and (Fig S3, Supplementary Items), respectively. The 
Mass Loss%Complexes Steps Temperature (oC) Leaving 
group Expt Calc
[Ni L12 Cl2 (H2o)2] .2H2O
1
2+ 3
4
50 -160
160-356+ 356-565
565-767
H2O
L2
Cl2
NiO
8.1
44.1+25.2
7.8
8.5
7.23
45.84+ 20.7+ 5.63
7.127
7.49
[Ni L22 Cl2 (H2o)2] .2H2O
1
2+3
4
50-173
173-560
560-850
H2O
L2
Cl2
NiO
8.9
40.1+28.3
7.9
11.3
8.27
41.82+23.66+6.43
8.145
10.515
[Ni L32 Cl2 (H2o)2] .2H2O
1
2+3
4
50-190
190-460
460-870
H2O
L2
Cl2
NiO
8.4
56.7+16.6
7.3
8.6
7.64
57.53+11.46+5.94
7.53
8.62
[Ni L42 Cl2 (H2o)2] .2H2O
1
2+3
4
50-176
176-334+ 334-444
444-900
H2O
L2
Cl2
NiO
8.7
52.3+ 17.3
7.9
8.5
8.29
51.34+ 12.16+ 6.30
7.98
8.608
[Ni L52 Cl2 (H2o)2] .2H2O
1
2 +3
4
50-201
201-430+430-557
557-828
H2O
L2
Cl2
NiO
10.7
57.9+13.4
7.2
10.7
9.03
57.21+6.77+7.02
8.89
9.369
[Ni L62 Cl2 (H2o)2] .2H2O
1
2
3
50-179
179-548
548-815
H2O
L2
Cl2
NiO
10.2
63.3
8.6
9.3
9.62
48+7.214+7.48
9.47
9.95
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decomposition of tetrazole derivatives is via Azide isomers followed by the elimination of nitrogen 
molecule and the formation of the corresponding nitrenes which are unstable [61, 62]. 
The TGA curve of Ni-L1 complex Fig. 3 shows four (4) stages in the decomposition process. The 
first stage of weight loss is observed in the range of temperature 50-160oC with a mass loss of 8.1% 
correspond to the loss of hydrated and coordinated water molecules (calc 7. 23%). 
0 200 400 600 800 1000
0
20
40
60
80
100
8.519%
7.8%
25.2%
44.1%
8.1%
TG
/%
Temp/oC
Fig. 3.Thermal decomposition of Ni-L1.
In the rage 160-565oC the organic moiety decompose in tow stage, the first one 160-356oC 
correspond to compound 2 (Fig.4) with mass loss of 44.1% (calc 45.84%). whereas the second stage 
356-565oC due to compounds 1+3 (Fig. 4) presents the rest of the ligands with mass loss of 25.2% 
(calc 26.33%). 
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R
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(2)
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Fig. 4. Mechanism of the thermal decomposition of  Ni-L1.
The last stage 565-767oC corresponds to the weight loss of two Chloride ions with a mass loss of 
7.8% (calc 7.127%). The TGA curve indicates a residual mass of 8.5% corresponding to the 
formation of metal oxide NiO (calc 7. 49%). these finding are similar to the one that reported for 
nickel complexes [63].
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The TGA curve of Ni-L4 complex (Fig S2, Supplementary Items) exhibited 8.7% of weight loss 
(calc 8.29%) in the range 50-176oC due to loss of hydrated and coordinated water molecules.
The next stage of decomposition is seen in the range 176-334oC, which corresponds to partial 
decomposition of the ligand (compound 1) (Fig S3, Supplementary Items), with mass loss of 52.3% 
(calc 51.34%). The final decomposition of the ligand (compounds 2+3) (Fig S3, Supplementary 
Items), is seen in the range 334-444oC with mass loss of 17.3% (calc 12.16+ 6.30%). The last stage 
444-900oC corresponds to the weight loss of two Chloride ions with a mass loss of 7.9% (calc 
7.98%). The curve indicates a residual mass of 8.5% corresponding to the formation of metal oxide 
NiO (calc 8.608%). This finding is similar to the one that reported for nickel complexes [63]. 
According to the results presented in Table 5, the Ni-L5 and Ni-L6 complexes undergo 
decomposition at a higher temperature than the rest of the complexes. This indicates that L5 and L6 
ligands give the most stable complexes with Ni (II).
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3.5.  Theoretical calculations
3.5.1. Geometry
Based on the analytical and spectral characterization results an octahedral geometry was suggested 
for all complexes. 
Table 6.Calculated structural parameters and NBO charge of the ligands and their complexes.
Parameters L1 L2 L3 L4 L5 L6
Bond lengths (Å)
N3-N2 1.332 1.330 1.316 1.314 1.332 1.332
N3-N4 1.395 1.396 1.408 1.409 1.395 1.396
Dihedral angles (°)
N2-N3-N4-C1 0.2 0.2 0.5 0.2 0.4 0.3
NBO Charge (e)
N3 -0.058 -0.059 -0.027 -0.025 -0.059 -0.061
Parameters Ni-L1 Ni-L2 Ni-L3 Ni-L4 Ni-L5 Ni-L6
Bond length(Å)
Ni-N3 2.093 2.121 2.095 2.099 2.094 2.099
Ni-N48 2.091 2.095 2.102 2.099 2.109 2.116
Ni-Cl92 2.423 2.439 2.405 2.407 2.407 2.419
Ni-Cl93 2.523 2.500 2.497 2.496 2.518 2.508
Ni-O94 2.102 2.093 2.099 2.098 2.098 2.094
Ni-O96 2.108 2.096 2.099 2.101 2.101 2.102
N3-N2 1.321 1.320 1.308 1.306 1.321 1.321
N48-N47 1.321 1.320 1.308 1.307 1.322 1.322
N3-N4 1.389 1.390 1.398 1.398 1.386 1.388
N48-N49 1.388 1.389 1.399 1.399 1.388 1.390
Bond angles(°)
N3-Ni-N48 175.6 172.7 174.2 173.4 176.7 174.3
Cl92-Ni-Cl93 179.0 178.5 177.9 179.4 178.2 179.7
O94-Ni-O96 163.9 165.7 165.3 165.4 165.1 165.1
N3-Ni-Cl92
N48-Ni-Cl93
86.0
89.5
85.2
91.3
86.9
94.6
87.1
93.2
89.3
94.1
88.4
94.1
N3-Ni-Cl93 94.7 96.0 91.2 93.4 89.1 91.6
N48-Ni-Cl92 89.7 87.5 87.3 86.3 87.5 85.9
O94-Ni-N3 85.8 94.9 94.7 94.8 94.5 95.7
O96-Ni-N48 85.4 95.9 94.3 94.8 94.6 94.5
O94-Ni-Cl92 98.7 96.3 98.3 97.0 97.9 96.9
O96-Ni-Cl93 81.9 82.9 82.4 82.6 82.2 82.3
Dihedral angles(°)
N3-Ni-N48-N47 78.6 85.6 83.4 78.7 91.8 74.4
N48-Ni-N3-N2 89.9 75.8 87.6 90.6 83.2 92.5
N2-N3-N4-Ni 160.8 154.0 172.2 169.0 177.4 172.2
N47-N48-N49-Ni 175.5 170.8 168.2 163.7 165.3 160.2
N2-N3-N4-C1 0.7 1.3 0.7 0.8 0.2 0.3
N47-N48-N49-C46 0.6 0.7 0.3 0.6 0.9 1.5
NBO Charges (e)
Ni 0.717 0.718 0.723 0.725 0.704 0.707
N3 -0.109 -0.108 -0.081 -0.079 -0.103 -0.105
N48 -0.104 -0.102 -0.080 -0.077 -0.100 -0.101
Cl92 -0.593 -0.605 -0.570 -0.575 -0.581 -0.593
Cl93 -0.631 -0.625 -0.619 -0.619 -0.632 -0.629
O94 -0.944 -0.944 -0.945 -0.945 -0.943 -0.593
O96 -0.945 -0.947 -0.945 -0.945 -0.944 -0.629
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After optimization of the proposed structures at DFT level [64, 65] for the different ligands and Ni 
(II) complexes, it is shown that the nickel complexes adopt an octahedral geometry Fig. 5. Selected 
bands lengths, distances, bond angles and dihedral angles for the different ligands and their nickel 
complexes are summarized in Table 6. As it is mentioned, all complexes adopt an  octahedral 
geometry formed by two ligands acting as monodentate through nitrogen atoms (N3), two Chloride 
atoms (Cl92, Cl93) and two molecules of coordinated water (O94, O96).
Fig. 5.Optimized structures of L1 ligand (a) and Ni-L1 complex(b).
In the free ligands, the bonds distances between 1.314-1.332Å and 1.395- 1.409 Å ranges 
correspond to N3-N2 double bonds and N3-N4 simple bonds, respectively for all the ligands. It is 
noted that these bonds are become shorter by 0.008-0.011 Å and 0.006-0.011 Å for N3-N2 and N3-
N4 respectively, upon complexation. It is also noted that the two Chloride atoms (Cl92, Cl93) and 
the two aqua (O94, O96) are in trans position with a band angels of 177.9° -179.7° and 163.9°-
165.7° respectively. The bond lengths of Ni-O94 which are in the ranges 2.093-2.102 Å seen 
shorter than Ni-O96 bonds lengths by 0.003-0.008 Å for all complexes, while the Ni-Cl92 bond 
lengths are shorter than Ni-Cl93 by 0.0061-0.111 Å. Bond angles N3-Ni-N48 are in the range 
172.7°-76.7° for all Ni(II) complexes. The N2-N3-N4-Ni and N47-N48-N49-Ni dihedral angles are 
in the range 154.0°-177.4° and 160.2°-175.5° respectively, which leads to deduct that the ligands 
are bonded into the metal ion in trans position. These results indicate a distorted octahedral 
geometry around the metal center [66].
3.5.2. NBO charges
In order to understand the site of electrophilic and nucleophilic attack [67], the natural bond orbital 
(NBO) analysis for each atom of the different complexes and their ligands were carried out. 
According to the calculated atomic charges presented in Table 6, the valence of nickel in its 
(b)(a)
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complexes is +2, while the net charge of this metal for all complexes is between 0.704-0.725e 
range. The decrease of the net charge of N3 atoms by 0.044-0.054e for the different ligands reveals 
the participation of electrons from ligands donor atoms to metallic ions and shows a covalent 
character of metal-ligand bands, which decrease in the following order: Ni-L5> Ni-L6> Ni-L1>Ni-
L2> Ni-L3> Ni-L4. 
3.5.3. Frontier molecular orbitals
The frontier molecular orbitals are important parameters and play role in understanding the 
chemical reactions and stability [68]. The HOMO (Highest occupied Molecular Orbital) presents 
the electron donating ability and the higher energy value EHOMO corresponds to the greater electron 
donating [69]. The LUMO (Lowest unoccupied Molecular Orbital) presents the ability of a 
molecule for receiving electrons and the lower energy value ELUMO corresponds to the smaller 
resistance to accept electrons [70]. LUMO-HOMO energy gap (∆E) is an important parameter that 
helps to understand the biological activity of molecules [71]. The HOMO, LUMO and ∆E energy 
gap of the ligands and nickel (II) complexes are grouped in Table 7 and schematized in Fig. 6 and 
Fig. 7. 
Table 7. Energy properties of the ligands and their complexes.
In the free ligands the HOMO is located on [2-(2-ethyl-4-methylthiazol) phenyl] and [2-(1-methyl 
pyrrol-2-yl) phenyl] groups, While the LUMO is located on [2-(2-ethyl-4-methylthiazol) phenyl], 
[2-(1-methyl pyrrol-2-yl) phenyl] groups and also on the tetrazole group. The LUMO is more 
extended on the ligands than the HOMO. For the nickel complexes, the HOMO density is 
essentially located on the metal and chloride ions. The LUMO density covers almost the two 
ligands in L3 and L4 complexes and it is situated around only one ligand for the rest of the 
Parameters L1 L2 L3 L4 L5 L6
HOMO (eV) -6.588 -5.939 -6.511 -5.810 -6.637 -5.986
LUMO (eV) -1.782 -1.458 -2.563 -2.490 -1.844 -1.510
Gap (eV) 4.806 4.481 3.948 3.320 4.793 4.476
Parameters Ni-L1 Ni-L2 Ni-L3 Ni-L4 Ni-L5 Ni-L6
HOMO (eV) -5.462 -5.324 -5.279 -5.128 -5.719 -5.539
LUMO (eV) -1.664 -1.942 -2.807 -2.702 -1.589 -1.786
∆E(eV) 3.798 3.382 2.472 2.426 4.130 3.753
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complexes. The energy gaps (∆E) of L3 and L4 complexes are the smallest suggesting a lower 
stability and a higher antimicrobial activity for these two complexes than the rest of the complexes 
[38].
Fig. 6. Energy levels of the HOMO, LUMO and energy gap for the free ligands.
Fig. 7. Energy levels of the HOMO, LUMO and energy gap for the synthesized complexes.
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3.5.4. Complexes stability
The binding energy Ebinding is estimated by the difference between the optimized complex energy 
(Ecomplex) and the sum of the isolated metal salt (MCl2) energy (EMCl2) and the isolated ligand energy 
(Eligand) [66]. The calculation of the binding energies Ebindingfor the synthesized complexes allow to 
compare the stability of these complexes. The binding energy Ebinding of the obtained structures are 
presented in Table 8 and performed as follows:    
 Ebinding = Ecomplex – (EMCl2 + Eligand)
As can be observed from Table8, the order of the binding energies of the synthesized complexes is 
as follows:   Ni-L4< Ni-L3< Ni-L2< Ni-L1< Ni-L6< Ni-L5
Table 8. Binding energies of the complexes obtained at DFT level.
3.6. Electrochemical study
The cyclic voltammetry was carried out, in DMSO solutions, in the potential range -2.5 to 2.5V and 
at room temperature, in order to evaluate the redox properties of the ligands and their nickel (II) 
complexes and to understand the electronic effect of the substituents on these properties. The redox 
potentials at sweep rate 0.1V.S-1 are collected in Table 9 for the ligands and those for the nickel (II) 
complexes are summarized in Table 10.
3.6.1. Redox properties of the ligands
The position 1 in L1 and L2 ligands is occupied by the benzyl (-CH2-Ph) group. In L3 and L4 ligands 
this position is occupied by the pivaloyl (tBu-CO-) group. The methyl (-CH3) group is in position 1 
in L5 and L6 ligands. The position 5 in L1, L3 and L5 ligands is occupied by [2-(2-ethyl-4-
methylthiazol) phenyl] group. In L2, L4 and L6 ligands the group [2-(1-methyl pyrrol-2-yl) phenyl] 
is in position 5 (scheme 1). 
Complexes Ebinding(Kcal/mol)
Ni-L1 -120.084
Ni-L2 -120.023
Ni-L3 -117.577
Ni-L4 -117.540
Ni-L5 -123.466
Ni-L6 -122.873
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Each ligand exhibits two irreversible reduction processes and one irreversible oxidation Fig. 8. 
Fig. 8.Cyclic voltammogram of  L5 ligand at 10-3 M in DMSO (100mV.S-1).
At potentials ranging from -0.87 to -0.98V, one cathodic wave is observed for all ligands and 
corresponds to an irreversible reduction process attributed to the tetrazole group [72].  The second 
reduction is seen at the potential range -0.28 to -0.35V and can be assigned to the reduction of the 
thiazole group in L1 and L5 ligands [73], of the pyrrol group in L2 and L6 ligands and of the pivaloyl 
group in L3 and L4 ligands. These results are in perfect agreement with the distribution of the 
LUMO that appears in L1, L2, L5 and L6 over the tetrazole, [2-(2-ethyl-4-methylthiazol) phenyl] 
group and [2-(1-methyl pyrrol-2-yl) phenyl] groups. In L3 and L4 ligands the LUMO is located also 
on the tetrazole and the pivaloyl groups (Fig. 6).
It is noted from Table 9 that the first observed reduction potential of the tetrazole group in the 
ligands is affected by the substituents in position 1 and 5. The reduction potential of the tetrazole 
group in L5 ligand is more negative than in L1 and L3 ligands. The potential of this group in L6 
ligand is more negative than in L2 and L4 ligands. These results are attributed to the electronic effect 
of the different substituents (methyl, benzyl and pivaloyl) located in position 1. The high electron 
donor effect of the methyl group carried by L5 and L6 ligands moves the reduction potentials of the 
tetrazole group towards more negative values [74]. It is also noted that the potentials of the 
reduction process of the tetrazole group in L1, L3 and L5 ligands are more negative when the 
tetrazole group is in L2, L4 and L6 ligands. This is also attributed to the various electronic effect of 
([2- (2-ethyl-4-methylthiazole) phenyl] and [2- (1-methylpyrrol-2-yl) phenyl]) substituents of the 
located in position 5. The electron withdrawing effect of [2- (2-ethyl-4-methylthiazole) phenyl] 
group carried by L1, L3 and L5 ligands is smaller than [2- (1-methylpyrrol-2-yl) phenyl] group 
carried by L2, L4 and L6 ligands. These results reveal that the reduction process of the tetrazole 
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group is more difficult in L1, L3 and L5 ligands than in L2, L4 and L6 ligands and it is the hardest in 
L5 and L6 ligands [57].
About the second reduction potential showed by the cyclic voltammogram of each ligand, it is 
noted that the reduction potential of the thiazole group in L5 ligand is more negative than when it 
is in L1 ligand. The reduction potential of the pyrrol group in L6 ligand is more negative than 
when it is in L2 ligand. The shift of the reduction potentials towards the negative values is 
attributed to the electronic effect of the benzyl substituent located in position 1 of L1 and L2 
ligands and the methyl substituents located in position 1 of L5 and L6 ligands [75]. The benzyl 
group has an electron withdrawing effect, whereas the methyl group presents an electron 
donating effect. Thus, the electron donating effect moves the reduction potentials of the thiazole 
and pyrrol groups in L5 and L6 ligands towards negative values. These results revealed that 
the reduction processes of the thiazole group in L5 ligand and the pyrrol group in L6 ligand are 
more difficult than in L1 and L2 ligands, respectively. The reduction potential of the pivaloyl 
group carried by L3 ligand is more negative than when it is carried by L4 ligand. This could 
be explained by the different electron withdrawing effect of the [2- (2-ethyl-4-methylthiazole) 
phenyl] and [2- (1-methylpyrrol-2-yl) phenyl] groups located in position 5 in L3 and L4 ligands, 
respectively. The electronic effect of [2- (2-ethyl-4-methylthiazole) phenyl] group is smaller 
than the electronic effect of [2- (1-methylpyrrol-2-yl) phenyl] group. Therefore, the 
reduction process of the pivaloyl group in L3 ligand is more difficult than in L4 ligand. 
Table 9. Redox potentials of the ligands.
Reduction OxidationCompounds
EPc (V) EPa (V) ∆E (V) EPa (V) EPc (V) ∆E (V)
L1 -0.92
-0.32
-0.46
-0.12
0.46
0.20
+0.88 +0.18 0.69
L2 -0.91
-0.31
-0.48
-0.12
0.41
0.18
+0.51 +0.13 0.38
L3 -0.88
-0.31
-0.44
-0.11
0.44
0.2
+0.97 +0.15 0.82
L4 -0.87
-0.28
-0.50
-0.12
0.37
0.16
+0.56 +0.14 0.42
L5 -0.98
-0.35
-0.51
-0.09
0.47
0.25
+0.74 +0.14 0.59
L6 -0.93
-0.33
-0.53
-0.15
0.39
0.18
+0.46 +0.18 0.28
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From +0.46 to +0.97V potential range, one anodic peak is showed and attributed to an irreversible 
oxidation of the thiazole groups in L1, L3 and L5 ligands and of the pyrrol groups in L2, L4 and L6 
ligands [76]. The attribution of the oxidation process is supported by the frontier orbital HOMO 
which is distributed around the [2- (2-ethyl-4-methylthiazole) phenyl] and the [2- (1-methylpyrrol- 
2-yl) phenyl] groups in ligands (Fig. 6). 
About the irreversible oxidation exhibited by each ligand, it is noted from the results given in Table 
9 that the oxidation potential of the thiazole group in L3 ligand is more positive than when in L1 and 
L5 ligands. The oxidation potential of the pyrrol group in L4 ligand is more positive than when in L2 
and L6 ligands. The anodic shift of the oxidation potential of the thiazole group in L3 ligand and 
pyrrol group in L4 ligand is due to the highest electron withdrawing effect of the pivaloyl group 
located in position 1 of these ligands [77]. These results indicate that the oxidation processes in L3 
and L4 ligands are easier than in the other ligands [78]. It can be also concluded from Table 9 that 
the oxidation process of the thiazole group in L1, L3 and L5 ligands is easier than the oxidation 
process of the pyrrol group in L2, L4 and L6 ligands.
3.6.2. Redox properties of the nickel (II) complexes
The cyclic voltammogram of Ni Cl2. 6H2O compound presents a cathodic potential EPc at -1.4V and 
its associated anodic peak Epa at -0.7V.
The redox properties of the nickel (II) complexes were also studied by cyclic voltammetry and the 
potential values are collected in Table 10. The cyclic voltammogram of the complexes showed the 
redox processes observed for the free ligands and an addition cathodic peak appeared at the 
potential range going from -1.42 to -1.48V (Fig S4, Supplementary material). By comparing the 
cyclic voltammogram of the complexes with those of the free ligands and that of Ni Cl2. 6H2O 
taken as reference, the additional cathodic process could be attributed to the reduction of Ni (II) to 
Ni (I) [79].
It is observed from Table 10 that the reduction potential of Ni (II/I) couple in the complexes is 
affected by the complexation and shifted to more negative potentials. The LUMOs of the complexes 
are distributed around the ligands, whereas the HOMOs are concentrated around the metal center. 
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Table 10. Redox potentials of the nickel complexes.
It is noted that the reduction potential of Ni (II/I) couple in the complexes is sensitive to the 
electronic effect of the different substituents located on the coordinated ligands. Going from the 
lowest electron-donating effect of pivaloyl to the highest one of methyl, the electron density on 
nickel ion increases, the difficulty to reduce the metal center increases and the reduction potential of 
Ni (II/I) couple shifts cathodically [80, 81]. 
It is noted from Table 10 that the cathodic peaks of the ligands when coordinated were affected by 
the complexation and shifted towards positive potentials. It is noted also that the oxidation potential 
of the ligands in the complexes moves to more negative potentials.
The complexation makes the reduction processes of the coordinated ligands easier and the oxidation 
processes of the coordinated ligands more difficult. While the reduction process of nickel (II) ion is 
more difficult in the complex than in Ni Cl2. H2O  salt [82, 83].
Reduction OxidationCompounds
EPc (V) EPa (V) ∆E (V) EPa (V) EPc (V) ∆E (V)
Ni-L1
-1.45
-0.89
-0.31
-0.75
-0.51
-0.14
0.71
0.38
0.17
+0.87 +0.16 0.71
Ni-L2
-1.44
-0.88
-0.28
-0.73
-0.51
-0.16
0.70
0.36
0.12
+0.59 +0.12 0.47
Ni-L3
-1.43
-0.86
-0.31
-0.73
-0.53
-0.13
0.71
0.33
0.16
+0.93 +0.26 0.67
Ni-L4
-1.42
-0.85
-0.27
-0.72
-0.53
-0.15
0.71
0.32
0.12
+0.54 +0.15 0.39
Ni-L5
-1.48
-0.94
-0.34
-0.79
-0.52
-0.09
0.69
0.41
0.24
+0.69 +0.11 0.59
Ni-L6
-1.46
-0.91
-0.32
-0.76
-0.54
-0.11
0.71
0.36
0.21
+0.44 +0.15 0.29
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3.7. Biological study 
3.7.1. Antimicrobial study
The in vitro antibacterial and antifungal activities of L1-L6 ligands and their nickel (II) complexes 
were evaluated by agar-well diffusion method [84]. The tested compounds were dissolved in 
Dimethyl Sulfoxide (DMSO) at two concentrations 10 and 5 mg/ ml. 
L1 and L2 ligands have the benzyl substituent in position 1. L3 and L4 ligands carry in the same 
position the pivaloyl group. L5 and L6 ligands have the same substituent methyl in position 1. L1, L3 
and L5 ligands carry [2-(2-ethyl-4-methylthiazol) phenyl] in position 5. This position is occupied by 
[2-(1-methyl pyrrol-2-yl) phenyl] in L2, L4 and L6 ligands (scheme 1).
3.7.1.1. Antibacterial study
L1-L6 ligands and their nickel (II) complexes were evaluated for their in vitro antibacterial activity 
and the susceptibility inhibition zones of the ligands and their complexes were measured in 
diameter (mm) and reported in Fig.9. All compounds were tested against two Gram-negative 
(Echerichia Coli, Klebsiella pneumoniae) and two Gram-positive (Staphylococcus aureus, 
Streptocoque D) bacterial strains. The obtained results were compared with that of the standard 
drugs (CTX: Cefotaxime for Gram-negative bacteria, GEN: Gentamicine for Gram-positive 
bacteria). 
The results depicted in Fig.9 revealed that most ligands displayed antibacterial activities against 
Gram-positive bacteria rather than Gram-negative bacteria. This behavior is related to the cell wall 
structure of the bacteria. The cell wall is essential to the survival of bacteria. According to the 
literature Gram-negative bacteria present a thin cell wall consisting of a few layers of peptidoglycan 
surrounded by a second lipid membrane containing lipopolysaccharides and lipoproteins, but in 
contrast the Gram-positive bacteria have a relative thick cell wall containing many layers of 
peptidoglycan and teichoic acid [85].  
Further, we notice that the different activities of the ligands are clearly related to the different 
substituents located in position 1 and 5 of the ligands and their electronic parameters [86, 30].
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Fig. 9. Values of inhibition zone diameter (nm) obtained by tetrazole derivatives and their nickel 
(II) complexes against bacterial strains
According to the results obtained, L1 exhibited a sensitive and selective antibacterial activity against 
Staphylococcus aureus with a concentration of 10mg/ml while the antibacterial activity disappears 
at 5mg/ml. The ligand L2 showed a sensitive activity against Staphylococcus aureus and a very 
sensitive activity against Streptococcus D with the two concentrations. L2 ligand is found more 
active than L1 ligand. This behavior could be explained by the different electron withdrawing effect 
of [2-(2-ethyl-4-methylthiazol) phenyl] and [2-(1-methyl pyrrol-2-yl) phenyl] substituents located 
in position 5 of the ligands. The electron withdrawing effect of [2-(2-ethyl-4-methylthiazol) phenyl] 
carried by L1 ligand is smaller than the electron withdrawing effect of [2-(1-methyl pyrrol-2-yl) 
phenyl] located on L2 ligand.  
The ligand L4 showed sensitive activity against Staphylococcus aureus at both concentrations, 
whereas it was very sensitive at 10 mg / ml and sensitive to 5 mg / ml against Streptocoque D. The 
ligand L3 showed a sensitive activity against both of Gram-positive bacteria at 10mg/ml and no 
activity at concentration 5mg/ml. L4 ligand has a better antibacterial activity than L3 ligand. The 
difference in the activity between L3 and L4 ligands is attributed to the different electronic 
withdrawing effect of [2-(2-ethyl-4-methylthiazol) phenyl] and [2-(1-methyl pyrrol-2-yl) phenyl] 
substituents carried by L3 and L4 ligands, respectively. The electronic withdrawing effect of          
[2-(1-methyl pyrrol-2-yl) phenyl] located on L4 ligand is bigger than the electronic withdrawing 
effect of [2-(2-ethyl-4-methylthiazol) phenyl] located on L3 ligand.
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The ligands L5 and L6 were inactive against all bacterial strains. Both of the ligands contain a 
moiety having an electron donor effect (-CH3) in position 1.
The ligands L3 and L4 present a higher activity than the other ligands. The electron withdrawing 
effect of the pivaloyl group situated in position 1 of L3 and L4 ligands increases the potency. While 
compounds L5and L6 contain in position 1 the methyl group, an electron donating group, found to 
weaken the antibacterial activity [87]. This result could be predicted by the DFT calculations. The 
HOMO-LUMO energy gap values ofL3 and L4 ligands are the lowest values (Table 7) which reflect 
the high antimicrobial activities of these compounds [15].  
The results obtained from the in vitro antibacterial studies reveal that the synthesized complexes 
were more toxic against all bacterial strains compared with their free ligands. Against 
Staphylococcus aureus, L1 and L2 complexes showed the same activity with their parent ligands at 
concentration 10 mg/ ml while they were inactive at concentration 5 mg / ml. Also L3 and L4 
complexes showed less antibacterial activity than their parent ligands. Against Echerichia coli L3, 
L4, L5 and L6 complexes were inactive as well as their ligands at concentrations 10 and 5 mg/ml. 
All nickel complexes with L1-L6 ligands showed an extremely sensitive activity against 
Streptococcus group D at concentration 10mg/ml and a very sensitive activity at concentration 
5mg/ml. This difference in antibacterial activity could be explained by the fact that the 
microorganisms have different cell wall constitution and/or the complexes might diffuse into 
bacterial cell membrane but stopped by a cellular mechanism [88].
The increase of the antibacterial activity of the complexes is may be due to the partial shared of the 
positive charge of the metal ion with the donor atoms of the coordinated ligands and possible π-
electron delocalization within the whole chelate ring that is formed during coordination. Such 
chelation increases the lipophilic character of the central metal atom in the complex and hence 
increases the hydrophobic character and liposolubility of the complex favoring its penetration 
through the lipid layers of the cell membrane [52]. 
3.7.1.2. Antifungal study
The ligands L1-L6 and their complexes with nickel (II) were also screened for their antifungal 
activity against Candida albicans and Trichophyton rubrum fungal strains. The inhibition zones 
were measured in diameter (mm) and presented in Fig. 10. The obtained results were compared 
with the stander Ketoconazole.
It was indicated from the presented results shown in Fig.10 that all the ligands were inactive against 
the tested organisms. Whereas nickel (II) complexes formed with these ligands were active against 
the tested organisms. It seems that the complexation of the ligands with nickel (II) enhance the 
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Anti-fungal activity of the ligands. This could be explained by Chelation theory [89], the polarity of 
metal ion would be reduced mainly because of partial sharing of its positive charge with the donor 
groups. Also the lipophilic nature of the metal ion increases which subsequently favors its 
permeation through the lipid layer of the cell membrane.
Fig.10. Values of inhibition zone diameter (nm) obtained by tetrazole derivatives and their nickel 
(II) complexes against fungal strains
The difference in the activity of the complexes formed with L1-L6 ligands is attributed to the 
different electron character of the various substituents located in position 1 and 5 of the coordinated 
ligands. 
L1 and L2 complexes showed an extremely sensitive antifungal activity against Candida albicans 
and Trichophyton rubrum at 10 and 5 mg/ml. L2 complex exhibited a better antifungal activity than 
L1 complex. This could be explained by the electronic effect of the different groups located in 
position 5 of the coordinated ligands. [2-(2-ethyl-4-methylthiazol) phenyl] group carried by 
L1complex has less electron withdrawing effect than [2-(1-methyl pyrrol-2-yl) phenyl] substituent 
carried by L2 complex.
L3 and L4 complexes present also an extremely sensitive antifungal activity against Candida 
albicans and Trichophyton rubrum at the two concentrations. L3 complex displayed less antifungal 
activity than L4 complex. This result is attributed to the smaller electron withdrawing effect of [2-
(2-ethyl-4-methylthiazol) phenyl] substituent carried by L3 complex compared with [2-(1-methyl 
pyrrol-2-yl) phenyl] substituent carried by L4 complex. 
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At concentrations 10 and 5 mg/ml, the complex with L6 ligand presented an extremely sensitive 
antifungal activity against Candida albicans and against Trichophyton rubrum, while L5 complex 
presented a very sensitive antifungal activity against the two fungal strains. This is probably due to 
the high electron withdrawing effect of [2-(1-methyl pyrrol-2-yl) phenyl] substituent carried by 
L6complex in comparison with [2-(2-ethyl-4-methylthiazol) phenyl] substituent carried by L5 
complex.
Regarding antifungal activity, L1, L2, L3 and L4 complexes exhibit a better activity than L5 and L6 
complexes. This could be related to the presence of the electron donating effect of the methyl group 
located in position 1 of the L5 and L6 coordinated ligands which decreases the antifungal activity of 
the molecules [90]. 
It is worth mentioning that incorporation of substituents with electron withdrawing effect at position 
1 of the coordinated ligands produced a high antimicrobial activity. Such an electronic 
effect decreases the electron density around the tetrazole ring, which decreases its lipophilic 
character which in turn deactivates the enzymes responsible for respiration processes and 
other essential enzymes in various metabolic pathways of the tested microbial strains [85, 91].
The antimicrobial study showed that the complexes are better active than the free ligands. This 
result is in perfect agreement with DFT calculations. The energy gaps ∆E (HOMO-LUMO) of the 
complexes are smaller than those of the free ligands. This suggests a lowest kinetic stability for the 
complexes compared to the free ligands and reflects a better antimicrobial activity for these 
complexes [92]. The complexes with L3 and L4 ligands were the most active ones. They possess the 
lowest energy gaps ∆E (HOMO-LUMO) values [93].
3.7.2. Antioxidant study 
The antioxidant activity is none other than the ability to act as free radical scavengers, either by 
hydrogen or by an electron of the corresponding compounds.
Many complexes have been extensively investigated for their antioxidant properties [94]. In this 
study we intend to evaluate the in vitro antioxidant properties of the ligands which are tetrazole 
derivatives and their nickel (II) complexes on the DPPH radical, which will be expressed as 
ascorbic acid equivalent. The percentage of activity was calculated and presented in Table 11.    
To evaluate the antioxidant property of the various compounds, the DPPH (2, 2-diphenyl-1-picryl-
hydrazyl) method was used. DPPH exhibits intense violet coloration due to delocalization of the 
free radical, characterized by an absorption band at 517 nm [95]. It is known that the DPPH as a 
free radical (DPPH.) is very stable and can accept either an electron or hydrogen radical. This leads 
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to recombination of the free radical of DPPH and a change of the initial color to yellow and a 
decrease in absorption at 517nm [96]. 
Table 11.Antioxidant activity of the ligands and their complexes.
AA: Antioxidant Activity      Eq: Equivalent
No significant radical scavenging activity was observed with Ni2+ in NiCl2.6H2O salt. Table 11 
shows that the ligands and their complexes have a better activity compared to the reference 
(Chlorogenic acid). The ligands L2, L4 and L6 exhibited a better antioxidant activity than L1, L3 and 
L5 ligands. This behavior could be related to the different substituents ([2-(2-ethyl-4-methylthiazol) 
phenyl] and [2-(1-methyl pyrrol-2-yl) phenyl]) located in position 5 of the ligands and their 
electronic effect.  The superior electron withdrawing character of [2-(1-methyl pyrrol-2-yl) phenyl] 
substituent located on L2, L4 and L6 ligands could explain the high antioxidant activity ofL2, L4 and 
L6 ligands [97, 98]. L3 and L4 ligands were the most active ones. This might be due to the presence 
of the pivaloyl group located in position 1 of L3 and L4 ligands and having the highest electron 
withdrawing effect. This result is in perfect agreement with the DFT calculations. The HOMO 
measures the electron donating ability of a compound [99]. The HOMO values of L3 and L4 ligands 
are respectively -6.511 and -5.810eV (Table 7) and are higher than the HOMO values of the rest of 
Compounds Ascorbic acid Eq (µM) AA  %
L1 27.9 22.74
L2 30.1 25.91
L3 31.3 27.79
L4 31.5 28.20
L5 26.7 20.76
L6 28.7 23.84
Ni-L1 30.8 27.06
Ni-L2 39.8 40.76
Ni-L3 33.5 31.14
Ni-L4 41.2 42.28
Ni-L5 30.2 26.14
Ni-L6 34.9 33.19
Chlorogenic acid 10.6 29.78
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the ligands. This indicates that L3 and L4 ligands are the best electron donors and consequently the 
best antioxidants ligands [92, 15].
The complexes showed a higher antioxidant activity than the free ligands. This is probably due to 
the coordination of DPPH to the metallic ion [100]. DFT calculations of the synthesized complexes 
confirm these results. Fig. 9 shows the energy levels of HOMO and LUMO for the Ni (II) 
complexes. The HOMO density is distributed over the metal and chloride ions while the LUMO 
density covers the ligands. The high HOMO energy values of L3 and L4 complexes show that these 
complexes are the highest electron donors and the best antioxidants.
4. CONCLUSION
A new series of nickel (II) complexes with new tetrazole derivatives previously synthesized, were 
isolated at solid state, characterized and tested as antimicrobial and antioxidant agents. Based on the 
results of the analytical and spectral techniques, all the ligands are coordinated to nickel (II) metal 
ion via nitrogen in an octahedral geometry. IR and TGA studies confirmed the presence of 
coordinated water in the coordination sphere. The DFT calculations established the optimized 
structure for nickel complexes. 
The electrochemical studies of the synthesized compounds showed that the reduction and the 
oxidation processes are affected by the electron character of the different substituents (Benzyl, 
Pivaloyl and Methyl) located in position 1 and ([2-(2-ethyl-4-methylthiazol) phenyl] and [2-(1-
methyl pyrrol-2-yl) phenyl]) located in position 5 of the coordinated ligands. . Electron donating 
effect moves reduction potentials toward negative values, while electron withdrawing effect shifts 
cathodically reduction potentials values. 
The electrochemical study revealed the Ni (II)/ Ni (I) reduction process, which was found to be 
more difficult in the presence of electron donating substituents in the coordinated ligand.   
The reduction processes are more easily accomplished in the complexes than in the free ligands. 
The complexation makes the oxidation processes of the thiazole and pyrrol groups in the complexes 
more difficult.
All the synthesized compounds were screened for their antimicrobial activity by agar well-diffusion 
method. The presence of different substituents (Benzyl, Pivaloyl and Methyl) located in position 1 
and ([2-(2-ethyl-4-methylthiazol) phenyl] and [2-(1-methyl pyrrol-2-yl) phenyl]) located in position 
5 of the ligands is responsible for the observed varied antimicrobial activities. The data obtained 
revealed that the ligands L1- L6 and their nickel (II) complexes show very good antibacterial activity 
against Gram-positive than Gram-negative bacteria. This is related to the outer membrane 
composition of Gram-negative bacteria. The most important antimicrobial activities have been 
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observed with 5-(2-(1-Pivalyltetrazol-5-yl) phenyl)-2-ethyl-4-methylthiazole (L3) and 5-(2-(1-
Methylpyrrol-2-yl) phenyl)-1-pivalyltetrazole (L4) ligands and their nickel (II) complexes. It is 
claimed that the Pivaloyl group with the highest electron withdrawing effect located in position 1 of 
5-(2-(1-Pivalyltetrazol-5-yl) phenyl)-2-ethyl-4-methylthiazole (L3) and 5-(2-(1-Methylpyrrol-2-yl) 
phenyl)-1-pivalyltetrazole (L4) ligands is responsible for enhancing antibacterial and antifungal 
activities. It is also indicated that the nickel (II) complexes showed better antimicrobial activities as 
compared to the parent ligands. This is attributed to the effect of the increased lipophilic character 
of these complexes upon complexation. The antimicrobial activity reveals also that the 
concentration plays a vital role in increasing the antimicrobial activity. As the concentration 
increases, the activity increases. Also the antifungal activity of the complexes was better as 
compared to their antibacterial activity.      
The antioxidant activity of L1-L6 ligands and their nickel (II) complexes was evaluated by the 
DPPH method. The results from various radical scavenging assay showed that the synthesized 
compounds exhibited a better activity in comparison to the reference (Chlorogenic acid). 
Compounds with electron withdrawing effect exert the highest antioxidant activity.
The antioxidant results revealed that the nickel (II) complexes exhibited better antioxidant activity 
compared to the free ligands; this could be explained by the coordination of DPPH with the metallic 
ion.    
It is concluded that EHOMO, ELUMO, NBO charge and binding energy values, given by the theoretical 
study, were the most significant descriptors for correlating the molecular structures of the 
synthesized compounds to their redox properties and biological activities. 
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Scheme 1.Structure of the different ligands.
Fig.1. Experimental Infrared vibrational spectra of L4 ligand (red line) and Ni–L4 complex (blue 
line) and Simulated IR spectrum of Ni–L4 complex (black line).
Fig. 2. Electronic spectra of (a) L5 and (b +c) Ni-L5.
Fig. 3. Thermal decomposition of Ni-L1.
Fig. 4. Mechanism of the thermal decomposition of Ni-L1.
Fig. 5. Optimized structures of L1 ligand (a) and Ni-L1 complex(b).
Fig. 6. Energy levels of the HOMO, LUMO and energy gap for the free ligands.
Fig. 7. Energy levels of the HOMO, LUMO and energy gap for the synthesized complexes
Fig. 8. Cyclic voltammogram of L5 ligand at 10-3 M in DMSO (100 mV.S-1).
Fig.9. Values of inhibition zone diameter (nm) obtained by tetrazole derivatives and their nickel (II) 
complexes against bacterial strains
Fig.10. Values of inhibition zone diameter (nm) obtained by tetrazole derivatives and their nickel 
(II) complexes against fungal strains
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Fig.1.Experimental Infrared vibrational spectra of L4 ligand (red line) and Ni–L4 complex (blue 
line) and Simulated IR spectrum of Ni–L4 complex (black line).
Fig. 2. Electronic spectra of (a) L5 and (b +c) Ni-L5
Fig. 3.Thermal decomposition of Ni-L1.
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Fig. 5. Optimized structures ofL1 ligand(a) and Ni-L1 complex(b)..
Fig. 6. Energy levels of the HOMO, LUMO and energy gap for the free ligands.
Fig. 7. Energy levels of the HOMO, LUMO and energy gap for the synthesized complexes
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Fig. 8.Cyclic voltammogram of L5 ligand at 103 M in DMSO (100mV.S-1).
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Fig.9. Values of inhibition zone diameter (nm) obtained by tetrazole derivatives and their 
nickel (II) complexes against bacterial strains
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Highlights
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 Novel Ni (II) complexes with a series of tetrazole derivatives have been characterized.
 Thermogravimetric analysis of the complexes has been performed.
 Octahedral structures for the Ni (II) complexes have been proposed and confirmed by DFT
calculations.
 The electrochemical behavior was determined by cyclic voltammetry.
 The complexes showed good antimicrobial activities.
 The antioxidant activity of these complexes has been evaluated.
 The effect of the functionalized tetrazole ring on the electrochemical behavior and biological
activities has been carefully studied.
Table 1. Physical properties of the metal complexes.
Table 2.The main absorbance bands (cm-1) in FT-IR spectra and their assignments for the ligands 
and their complexes.
Table 3.The main absorbance bands (cm-1) of the ligands in UV-visible and their assignments.
Table4 The main absorbance bands (cm-1) of Ni (II) complexes in UV-visible and their 
assignments.
Table 5.Thermogravimetric results of the complexes.
Table 6.Calculated structural parameters and NBO charge of the ligands and their complexes.
Table 7.Energy properties of the ligands and their complexes.
Table8.Binding energies of the complexes obtained at DFT level.
Table 9.Redox potentials of the ligands.
Table 10.Redox potentials of the nickel complexes.
Table 11.Antioxidant activity of the ligands and their complexes.
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Table 1. Physical properties of the metal complexes.
Complexes Melting point °C Yield % Conductance
Ω-1 cm2 mol-1
μeff
(B.M)
[Ni L12 Cl2(H2O)2] .2H2O >300 55 18 3.01
[Ni L22 Cl2 (H2O)2] .2H2O >300 51 26 3.14
[Ni L32 Cl2 (H2O)2] .2H2O >300 39 37 3.30
[Ni L42 Cl2 (H2O)2] .2H2O >300 46 41 3.41
[Ni L52 Cl2 (H2O)2] .2H2O >300 54 33 2.77
[Ni L62 Cl2 (H2O)2] .2H2O >300 56 13 2.82
52
Table 2.The main absorbance bands (cm-1) in FT-IR spectra and their assignments for the ligands 
and their complexes.
Compound υ (C=N) tetrazole υ (N=N) υ (N-N=N) υ(OH)H2OCoord υ (C=O) υ (M-O) υ (M-N)
L1 1510
(1518)
1457
(1459)
1329
(1326)
- - - -
L2 1514
(1497)
1461
(1452)
1316
(1311)
- - - -
L3 1489
(1481)
1452
(1457)
1326
(1330)
- 1687
(1691)
- -
L4 1494
(1491)
1456
(1465)
1309
(1311)
- 1683
(1681)
- -
L5 1483
(1476)
1447
(1466)
1319
(1318)
- - - -
L6 1488
(1482)
1452
(1458)
1284
(1278)
- - - -
Ni-L1 1500
(1492)
1431
(1418)
1254
(1252)
3479
(3526)
- 467
(424)
525
(521)
Ni-L2 1475
(1474)
1416
(1416)
1265
(1267)
3468
(3515)
- 464
(423)
524
(545)
Ni-L3 1473
(1463)
1418
(1401)
1252
(1258)
3477
(3542)
1637
(1643)
471
(433)
522
(518)
Ni-L4 1480
(1470)
1410
(1397)
1263
(1259)
3448
(3545)
1631
(1634)
465
(431)
523
(531)
Ni-L5 1483
(1481)
1418
(1409)
1258
(1264)
3467
(3539)
- 464
(449)
536
(538)
Ni-L6 1475
(1470)
1408
(1410)
1271
(1285)
3467
(3531)
- 464
(450)
525
(543)
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Table 3.The main absorbance bands (cm-1) of the ligands in UV-visible and their assignments.
Ligand λ nm (cm-1) ε (mole-1. L. cm-1) Electronic transitions
L1 273 (36630)
315 (31055)
30300
14500
π→π*
n→π*
L2 246 (40650)
317 (31545)
14270
22900
π→π*
n→π*
L3 250 (40000)
302 (33557)
14890
18300
π→π*
π→π*
L4 244 (40983)
282(35971)
11330
28200
π→π*
n→π*
L5 281 (35587)
316 (31646)
34600
22100
π→π*
n→π*
L6 275 (36101)
324 (30864)
68800
16700
π→π*
n→π*
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Table4.The main absorbance bands (cm-1) of Ni (II) complexes in UV-visible and their 
assignments.
Compounds Wavenumber
ῡ (cm-1)
Wavelength
λ (nm)
Molar coefficient absorption
(mole-1. L. cm-1)
Electronic transition
Ni-L1
37735
31055
25316
15060
10080
265
322
395
664
992
1009
583
302
110
78
π→π*
n→π*
3A2g(F) →3T2g(F)
3A2g(F) →3T1g(F)
3A2g(F) →3T2g(P)
Ni-L2
36630
30303
25706
14925
10152
273
330
389
670
985
833
490
343
154
112
π→π*
n→π*
3A2g(F) →3T2g(F)
3A2g(F) →3T1g(F)
3A2g(F) →3T2g(P)
Ni-L3
36496
30864
25575
15015
10141
274
324
391
666
986
718
453
287
145
111
π→π*
n→π*
3A2g(F) →3T2g(F)
3A2g(F) →3T1g(F)
3A2g(F) →3T2g(P)
Ni-L4
40816
31446
25641
14771
10141
275
318
390
677
986
938
736
402
160
101
π→π*
n→π*
3A2g(F) →3T2g(F)
3A2g(F) →3T1g(F)
3A2g(F) →3T2g(P)
Ni-L5
37735
30864
25316
15015
10070
265
324
395
666
993
1273
547
304
104
70
π→π*
n→π*
3A2g(F) →3T2g(F)
3A2g(F) →3T1g(F)
3A2g(F) →3T2g(P)
Ni-L6
37735
30769
25316
14992
10091
265
325
395
667
991
1000
483
321
139
97
π→π*
n→π*
3A2g(F) →3T2g(F)
3A2g(F) →3T1g(F)
3A2g(F) →3T2g(P)
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Table 5.Thermogravimetric results of the complexes.
Mass Loss%Complexes Steps Temperature (oC) Leaving 
group Expt Calc
[Ni L12 Cl2 (H2o)2] .2H2O
1
2+ 3
4
50 -160
160-356+ 356-565
565-767
H2O
L2
Cl2
NiO
8.1
44.1+25.2
7.8
8.5
7.23
45.84+ 20.7+ 5.63
7.127
7.49
[Ni L22 Cl2 (H2o)2] .2H2O
1
2+3
4
50-173
173-560
560-850
H2O
L2
Cl2
NiO
8.9
40.1+28.3
7.9
11.3
8.27
41.82+23.66+6.43
8.145
10.515
[Ni L32 Cl2 (H2o)2] .2H2O
1
2+3
4
50-190
190-460
460-870
H2O
L2
Cl2
NiO
8.4
56.7+16.6
7.3
8.6
7.64
57.53+11.46+5.94
7.53
8.62
[Ni L42 Cl2 (H2o)2] .2H2O
1
2+3
4
50-176
176-334+ 334-444
444-900
H2O
L2
Cl2
NiO
8.7
52.3+ 17.3
7.9
8.5
8.29
51.34+ 12.16+ 6.30
7.98
8.608
[Ni L52 Cl2 (H2o)2] .2H2O
1
2 +3
4
50-201
201-430+430-557
557-828
H2O
L2
Cl2
NiO
10.7
57.9+13.4
7.2
10.7
9.03
57.21+6.77+7.02
8.89
9.369
[Ni L62 Cl2 (H2o)2] .2H2O
1
2
3
50-179
179-548
548-815
H2O
L2
Cl2
NiO
10.2
63.3
8.6
9.3
9.62
48+7.214+7.48
9.47
9.95
56
Table 6.Calculated structural parameters and NBO charge of the ligands and their complexes.
Parameters L1 L2 L3 L4 L5 L6
Bond lengths (Å)
N3-N2 1.332 1.330 1.316 1.314 1.332 1.332
N3-N4 1.395 1.396 1.408 1.409 1.395 1.396
Dihedral angles 
(°)
N2-N3-N4-C1 0.2 0.2 0.5 0.2 0.4 0.3
NBO Charge (e)
N3 -0.058 -0.059 -0.027 -0.025 -0.059 -0.061
Parameters Ni-L1 Ni-L2 Ni-L3 Ni-L4 Ni-L5 Ni-L6
Bond length(Å)
Ni-N3 2.093 2.121 2.095 2.099 2.094 2.099
Ni-N48 2.091 2.095 2.102 2.099 2.109 2.116
Ni-Cl92 2.423 2.439 2.405 2.407 2.407 2.419
Ni-Cl93 2.523 2.500 2.497 2.496 2.518 2.508
Ni-O94 2.102 2.093 2.099 2.098 2.098 2.094
Ni-O96 2.108 2.096 2.099 2.101 2.101 2.102
N3-N2 1.321 1.320 1.308 1.306 1.321 1.321
N48-N47 1.321 1.320 1.308 1.307 1.322 1.322
N3-N4 1.389 1.390 1.398 1.398 1.386 1.388
N48-N49 1.388 1.389 1.399 1.399 1.388 1.390
Bond angles(°)
N3-Ni-N48 175.6 172.7 174.2 173.4 176.7 174.3
Cl92-Ni-Cl93 179.0 178.5 177.9 179.4 178.2 179.7
O94-Ni-O96 163.9 165.7 165.3 165.4 165.1 165.1
N3-Ni-Cl92
N48-Ni-Cl93
86.0
89.5
85.2
91.3
86.9
94.6
87.1
93.2
89.3
94.1
88.4
94.1
N3-Ni-Cl93 94.7 96.0 91.2 93.4 89.1 91.6
N48-Ni-Cl92 89.7 87.5 87.3 86.3 87.5 85.9
O94-Ni-N3 85.8 94.9 94.7 94.8 94.5 95.7
O96-Ni-N48 85.4 95.9 94.3 94.8 94.6 94.5
O94-Ni-Cl92 98.7 96.3 98.3 97.0 97.9 96.9
O96-Ni-Cl93 81.9 82.9 82.4 82.6 82.2 82.3
Dihedral angles(°)
N3-Ni-N48-N47 78.6 85.6 83.4 78.7 91.8 74.4
N48-Ni-N3-N2 89.9 75.8 87.6 90.6 83.2 92.5
N2-N3-N4-Ni 160.8 154.0 172.2 169.0 177.4 172.2
N47-N48-N49-Ni 175.5 170.8 168.2 163.7 165.3 160.2
N2-N3-N4-C1 0.7 1.3 0.7 0.8 0.2 0.3
N47-N48-N49-
C46
0.6 0.7 0.3 0.6 0.9 1.5
NBO Charges (e)
Ni 0.717 0.718 0.723 0.725 0.704 0.707
N3 -0.109 -0.108 -0.081 -0.079 -0.103 -0.105
N48 -0.104 -0.102 -0.080 -0.077 -0.100 -0.101
Cl92 -0.593 -0.605 -0.570 -0.575 -0.581 -0.593
Cl93 -0.631 -0.625 -0.619 -0.619 -0.632 -0.629
O94 -0.944 -0.944 -0.945 -0.945 -0.943 -0.593
O96 -0.945 -0.947 -0.945 -0.945 -0.944 -0.629
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Table 7.Energy properties of the ligands and their complexes.
Table8.Binding energies of the complexes obtained at DFT level.
Complexes Ebinding(Kcal/mol)
Ni-L1 -120.084
Ni-L2 -120.023
Ni-L3 -117.577
Ni-L4 -117.540
Ni-L5 -123.466
Ni-L6 -122.873
Parameters L1 L2 L3 L4 L5 L6
HOMO (eV) -6.588 -5.939 -6.511 -5.810 -6.637 -5.986
LUMO (eV) -1.782 -1.458 -2.563 -2.490 -1.844 -1.510
Gap (eV) 4.806 4.481 3.948 3.320 4.793 4.476
Parameters Ni-L1 Ni-L2 Ni-L3 Ni-L4 Ni-L5 Ni-L6
HOMO (eV) -5.462 -5.324 -5.279 -5.128 -5.719 -5.539
LUMO (eV) -1.664 -1.942 -2.807 -2.702 -1.589 -1.786
∆E(eV) 3.798 3.382 2.472 2.426 4.130 3.753
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Table 9.Redox potentials of the ligands.
Reduction OxidationCompounds
EPc (V) EPa (V) ∆E (V) EPa (V) EPc (V) ∆E (V)
L1 -0.92
-0.32
-0.46
-0.12
0.46
0.20
+0.88 +0.18 0.69
L2 -0.91
-0.31
-0.48
-0.12
0.41
0.18
+0.51 +0.13 0.38
L3 -0.88
-0.31
-0.44
-0.11
0.44
0.2
+0.97 +0.15 0.82
L4 -0.87
-0.28
-0.50
-0.12
0.37
0.16
+0.56 +0.14 0.42
L5 -0.98
-0.35
-0.51
-0.09
0.47
0.25
+0.74 +0.14 0.59
L6 -0.93
-0.33
-0.53
-0.15
0.39
0.18
+0.46 +0.18 0.28
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Table 10.Redox potentials of the nickel complexes.
.
Reduction OxidationCompounds
EPc (V) EPa (V) ∆E (V) EPa (V) EPc (V) ∆E (V)
Ni-L1 -1.45
-0.89
-0.31
-0.75
-0.51
-0.14
0.71
0.38
0.17
+0.87 +0.16 0.71
Ni-L2 -1.44
-0.88
-0.28
-0.73
-0.51
-0.16
0.70
0.36
0.12
+0.59 +0.12 0.47
Ni-L3 -1.43
-0.86
-0.31
-0.73
-0.53
-0.13
0.71
0.33
0.16
+0.93 +0.26 0.67
Ni-L4 -1.42
-0.85
-0.27
-0.72
-0.53
-0.15
0.71
0.32
0.12
+0.54 +0.15 0.39
Ni-L5 -1.48
-0.94
-0.34
-0.79
-0.52
-0.09
0.69
0.41
0.24
+0.69 +0.11 0.59
Ni-L6 -1.46
-0.91
-0.32
-0.76
-0.54
-0.11
0.71
0.36
0.21
+0.44 +0.15 0.29
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Table 11.Antioxidant activity of the ligands and their complexes.
Compounds Ascorbic acid Eq (µM) AA  %
L1 27.9 22.74
L2 30.1 25.91
L3 31.3 27.79
L4 31.5 28.20
L5 26.7 20.76
L6 28.7 23.84
Ni-L1 30.8 27.06
Ni-L2 39.8 40.76
Ni-L3 33.5 31.14
Ni-L4 41.2 42.28
Ni-L5 30.2 26.14
Ni-L6 34.9 33.19
Chlorogenic acid 10.6 29.78
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